Skip to main content

A Cell Culture Model for Persistent HCV Infection

  • Protocol
  • First Online:
Hepatitis C Virus Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1911))

Abstract

Chronic hepatitis C virus (HCV) infection affects millions of humans throughout the globe, causing liver disease and hepatocellular carcinoma. Persistence of the virus in the infected host can last for decades as a result of a faulty immune response that fails to clear the virus while constituting a major player in viral pathogenesis. In addition to evading immune responses, HCV has evolved intracellular survival strategies that enable persistent replication without directly killing the host cell.

After the generation of cell culture infection models for HCV, the knowledge about this virus and host-virus interactions acquired in the last decade has been greatly increased. Interestingly, persistent infection can also be established in cell culture. This model recapitulates persistent HCV RNA replication and viral protein expression as well as infectious progeny virus assembly and secretion and may be used to study not only these aspects of the virus replication cycle but also to study host-virus interactions in a model of prolonged HCV infection. In this chapter, we describe a methodology to generate persistently HCV-infected cultures and to monitor viral load and progeny virus production. Also, we provide generic protocols to study the impact of chemical compounds and host-targeting shRNAs to illustrate the applications of this model in the study of HCV infection in cell culture.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thrift AP, El-Serag HB, Kanwal F (2017) Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol 14:122–123

    Article  Google Scholar 

  2. Guidotti LG, Chisari FV (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1:23–61

    Article  CAS  Google Scholar 

  3. Rehermann B (2013) Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med 19:859–868

    Article  CAS  Google Scholar 

  4. Zeuzem S, Herrmann E (2002) Dynamics of hepatitis C virus infection. Ann Hepatol 1:56–63

    PubMed  Google Scholar 

  5. Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G et al (2006) Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol 80:11082–11093

    Article  CAS  Google Scholar 

  6. Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76:13001–13014

    Article  CAS  Google Scholar 

  7. Walters K-A, Syder AJ, Lederer SL, Diamond DL, Paeper B, Rice CM et al (2009) Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog 5:e1000269

    Article  Google Scholar 

  8. Mishima K, Sakamoto N, Sekine-Osajima Y, Nakagawa M, Itsui Y, Azuma S et al (2010) Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants. Virology 405:361–369

    Article  CAS  Google Scholar 

  9. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42:3858–3863

    CAS  PubMed  Google Scholar 

  10. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z et al (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791–796

    Article  CAS  Google Scholar 

  11. Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W, Chisari FV (2008) Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol 82:2120–2129

    Article  CAS  Google Scholar 

  12. Gastaminza P, Whitten-Bauer C, Chisari FV (2010) Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection. Proc Natl Acad Sci U S A 107:291–296

    Article  CAS  Google Scholar 

  13. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR et al (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102:9294–9299

    Article  CAS  Google Scholar 

  14. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV et al (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449:919–922

    Article  CAS  Google Scholar 

  15. Law M, Maruyama T, Lewis J, Giang E, Tarr AW, Stamataki Z et al (2008) Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med 14:25–27

    Article  CAS  Google Scholar 

  16. Wakita T (2009) Isolation of JFH-1 strain and development of an HCV infection system. Methods Mol Biol 510:305–327

    Article  CAS  Google Scholar 

  17. Gastaminza P, Kapadia SB, Chisari FV (2006) Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol 80:11074–11081

    Article  CAS  Google Scholar 

  18. Friesland M, Mingorance L, Chung J, Chisari FV, Gastaminza P (2013) Sigma-1 receptor regulates early steps of viral RNA replication at the onset of hepatitis C virus infection. J Virol 87:6377–6390

    Article  CAS  Google Scholar 

  19. Wild AT, Gandhi N, Chettiar ST, Aziz K, Gajula RP, Williams RD et al (2013) Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma. PLoS One 8:e65726

    Article  CAS  Google Scholar 

  20. Sainz B Jr, Barretto N, Uprichard SL (2009) Hepatitis C virus infection in phenotypically distinct Huh7 cell lines. PLoS One 4:e6561

    Article  Google Scholar 

  21. Pawlotsky JM, Feld JJ, Zeuzem S, Hoofnagle JH (2015) From non-A, non-B hepatitis to hepatitis C virus cure. J Hepatol 62:S87–S99

    Article  CAS  Google Scholar 

  22. Migliaccio G, Tomassini JE, Carroll SS, Tomei L, Altamura S, Bhat B et al (2003) Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J Biol Chem 278:49164–49170

    Article  CAS  Google Scholar 

Download references

Acknowledgment

This protocol is based on work initially developed at Dr. Francis V. Chisari’s laboratory at The Scripps Research Institute (La Jolla, CA) in collaboration with Dr. Takaji Wakita’s group at the Tokyo Metropolitan Institute of Medical Science (Tokyo, Japan) and was originally generated and improved with the essential contribution of Jin Zhong (Pasteur Institute in Shanghai), Sharookh Kapadia (Genentech), Guofeng Cheng (Gilead), Susan Uprichard (University of Illinois, Chicago), and specially Stefan Wieland (University Hospital of Basel). We would like to thank Gema Calvo and Martina Friesland (CNB-CSIC) for excellent technical assistance and Dr. Urtzi Garaigorta for critically reviewing the manuscript. This work was supported by grant SAF2014-52400-R from the Spanish Ministry of Economy.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pablo Gastaminza .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Castro, V., Ávila-Pérez, G., Mingorance, L., Gastaminza, P. (2019). A Cell Culture Model for Persistent HCV Infection. In: Law, M. (eds) Hepatitis C Virus Protocols . Methods in Molecular Biology, vol 1911. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8976-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8976-8_10

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-8975-1

  • Online ISBN: 978-1-4939-8976-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics